Literature DB >> 17671358

Crystallization and X-ray analysis of the T = 4 particle of hepatitis B capsid protein with an N-terminal extension.

Wen Siang Tan1, Iain W McNae, Kok Lian Ho, Malcolm D Walkinshaw.   

Abstract

Hepatitis B core (HBc) particles have been extensively exploited as carriers for foreign immunological epitopes in the development of multicomponent vaccines and diagnostic reagents. Crystals of the T = 4 HBc particle were grown in PEG 20,000, ammonium sulfate and various types of alcohols. A temperature jump from 277 or 283 to 290 K was found to enhance crystal growth. A crystal grown using MPD as a cryoprotectant diffracted X-rays to 7.7 A resolution and data were collected to 99.6% completeness at 8.9 A. The crystal belongs to space group P2(1)2(1)2(1), with unit-cell parameters a = 352.3, b = 465.5, c = 645.0 A. The electron-density map reveals a protrusion that is consistent with the N-terminus extending out from the surface of the capsid. The structure presented here supports the idea that N-terminal insertions can be exploited in the development of diagnostic reagents, multicomponent vaccines and delivery vehicles into mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671358      PMCID: PMC2335152          DOI: 10.1107/S1744309107033726

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  23 in total

1.  A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle.

Authors:  Boerries Brandenburg; Lars Stockl; Cindy Gutzeit; Martin Roos; Joachim Lupberger; Ruth Schwartlander; Hans Gelderblom; Igor M Sauer; Peter Hans Hofschneider; Eberhard Hildt
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

2.  Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA.

Authors:  A Zlotnick; N Cheng; S J Stahl; J F Conway; A C Steven; P T Wingfield
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Immunogenicity of peptide fusions to hepatitis B virus core antigen.

Authors:  S J Stahl; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

Review 5.  HBV core particles as a carrier for B cell/T cell epitopes.

Authors:  P Pumpens; E Grens
Journal:  Intervirology       Date:  2001       Impact factor: 1.763

6.  Hepatitis B virus core antigen: enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen.

Authors:  Wen Siang Tan; Michael R Dyson; Kenneth Murray
Journal:  Biol Chem       Date:  2003-03       Impact factor: 3.915

Review 7.  Immunology of hepatitis B infection.

Authors:  Maria-Christina Jung; Gerd R Pape
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

8.  Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis.

Authors:  S Stahl; P MacKay; M Magazin; S A Bruce; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

9.  Localization of the N terminus of hepatitis B virus capsid protein by peptide-based difference mapping from cryoelectron microscopy.

Authors:  J F Conway; N Cheng; A Zlotnick; S J Stahl; P T Wingfield; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

View more
  9 in total

1.  Role of the propeptide in controlling conformation and assembly state of hepatitis B virus e-antigen.

Authors:  Norman R Watts; James F Conway; Naiqian Cheng; Stephen J Stahl; Alasdair C Steven; Paul T Wingfield
Journal:  J Mol Biol       Date:  2011-04-02       Impact factor: 5.469

Review 2.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

3.  Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition.

Authors:  Elif Eren; Norman R Watts; Altaira D Dearborn; Ira W Palmer; Joshua D Kaufman; Alasdair C Steven; Paul T Wingfield
Journal:  Structure       Date:  2018-08-09       Impact factor: 5.006

4.  Hepatitis B Virus Genotype G forms core-like particles with unique structural properties.

Authors:  J J H Cotelesage; C Osiowy; C Lawrence; S L DeVarennes; S Teow; D R Beniac; T F Booth
Journal:  J Viral Hepat       Date:  2011-06       Impact factor: 3.728

5.  An N-terminal extension to the hepatitis B virus core protein forms a poorly ordered trimeric spike in assembled virus-like particles.

Authors:  Richard McGonigle; Wei Boon Yap; Swee Tin Ong; Derek Gatherer; Saskia E Bakker; Wen Siang Tan; David Bhella
Journal:  J Struct Biol       Date:  2014-12-31       Impact factor: 2.867

6.  pH-responsive Virus-like Nanoparticles with Enhanced Tumour-targeting Ligands for Cancer Drug Delivery.

Authors:  Roya Biabanikhankahdani; Noorjahan Banu Mohamed Alitheen; Kok Lian Ho; Wen Siang Tan
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

7.  A Dual Bioconjugated Virus-Like Nanoparticle as a Drug Delivery System and Comparison with a pH-Responsive Delivery System.

Authors:  Roya Biabanikhankahdani; Kok Lian Ho; Noorjahan Banu Alitheen; Wen Siang Tan
Journal:  Nanomaterials (Basel)       Date:  2018-04-13       Impact factor: 5.076

8.  Thermally-responsive Virus-like Particle for Targeted Delivery of Cancer Drug.

Authors:  Qiu Xian Thong; Roya Biabanikhankahdani; Kok Lian Ho; Noorjahan Banu Alitheen; Wen Siang Tan
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

9.  Targeted delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells overexpressing epithelial growth factor receptor (EGFR) using virus-like nanoparticles.

Authors:  Bee Koon Gan; Kamal Rullah; Chean Yeah Yong; Kok Lian Ho; Abdul Rahman Omar; Noorjahan Banu Alitheen; Wen Siang Tan
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.